WEKO3
アイテム
3)成長ホルモン療法における骨代謝の検討(シンポジウム 骨粗鬆症の病態・治療・予防, 第493回新潟医学会)
http://hdl.handle.net/10191/40473
http://hdl.handle.net/10191/4047356b92329-4d74-4ef7-b396-7c7f6370739a
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
108(11)_815-819.pdf (883.2 kB)
|
|
| Item type | 紀要論文 / Departmental Bulletin Paper(1) | |||||
|---|---|---|---|---|---|---|
| 公開日 | 2016-03-29 | |||||
| タイトル | ||||||
| タイトル | 3)成長ホルモン療法における骨代謝の検討(シンポジウム 骨粗鬆症の病態・治療・予防, 第493回新潟医学会) | |||||
| タイトル | ||||||
| タイトル | 3)成長ホルモン療法における骨代謝の検討(シンポジウム 骨粗鬆症の病態・治療・予防, 第493回新潟医学会) | |||||
| 言語 | en | |||||
| 言語 | ||||||
| 言語 | jpn | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | growth hormine | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | bone metabolism | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | bone formation | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | bone mineral density | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | 成長ホルモン | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | 骨代謝 | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | 骨形成 | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | 骨塩量 | |||||
| 資源タイプ | ||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
| 資源タイプ | departmental bulletin paper | |||||
| その他のタイトル | ||||||
| その他のタイトル | Effects of Growth Hormone on Bone Metabolism in Children with Growth Hormone Deficiency (Pathogenesis, Treatment and Prevention of Osteoporosis) | |||||
| 著者 |
菊池, 透
× 菊池, 透× 橋本, 尚士× 川崎, 琢也× 内山, 聖 |
|||||
| 著者別名 | ||||||
| 識別子Scheme | WEKO | |||||
| 識別子 | 117914 | |||||
| 姓名 | Kikuchi, Toru | |||||
| 著者別名 | ||||||
| 識別子Scheme | WEKO | |||||
| 識別子 | 117915 | |||||
| 姓名 | Hashimoto, Naoshi | |||||
| 著者別名 | ||||||
| 識別子Scheme | WEKO | |||||
| 識別子 | 117916 | |||||
| 姓名 | Kawasaki, Takuya | |||||
| 著者別名 | ||||||
| 識別子Scheme | WEKO | |||||
| 識別子 | 117917 | |||||
| 姓名 | Uchiyama, Makoto | |||||
| 抄録 | ||||||
| 内容記述タイプ | Abstract | |||||
| 内容記述 | The effects of growth hormone (GH) on bone metabolism were studied in 8 GH-deficient children. Biochemical markers for bone metabolism, such as osteocalcin, alkakine phoshatase (ALP), insulin like growth factor-I (IGF-I), calcium, phosphate, renal tubular reabsorption of phosphate (%TRP), vaitamin D_3, parathyroid hormone (PTH) and calcitonin, and bone mineral density (BMD) were measured before and 1, 2, 3, 6, 9, 12 months after treatment with GH. BMD was determined by dual energy X-ray absorptiometry at 2nd～4th lumbar spine by using a model QDR 1,000 (Hologic Corp., Waltham, Massachusetts). All children had significant increment of body height (BH) SD score, height velocity and height velocity SD score. We compared these makers and BMD of pretreatment with those of posttreatment. The following results were obtained. 1) Significant increment of osteocalcin, ALP and IGF-I serum level were found. 2) Serum levels of Calcium and phosphate, and %TRP showed a tendency to increase. 3) Serum level of 1,25-(OH)_2 vaitamin D_3 showed a tendency to increase. However serum levels of 25-(OH) vaitamin D_3 and 24,25-(OH)_2 vaitamin D_3 showed a tendency to decrease. 4) No significant chages in PTH C-terminal and calcitonin levels were found. 5) A significant increment of BMD was found. However no significant variation of BMD/BH was found. Bone metabolism is regulated by numerous hormones and local growth factors. Our findings suggest that the treatment with GH may affect this network of bone metabolism and stimulat bone turnover, especially bone formation. | |||||
| 書誌情報 |
新潟医学会雑誌 en : 新潟医学会雑誌 巻 108, 号 11, p. 815-819, 発行日 1994-11 |
|||||
| 出版者 | ||||||
| 出版者 | 新潟医学会 | |||||
| ISSN | ||||||
| 収録物識別子タイプ | ISSN | |||||
| 収録物識別子 | 00290440 | |||||
| 書誌レコードID | ||||||
| 収録物識別子タイプ | NCID | |||||
| 収録物識別子 | AN00182415 | |||||
| 著者版フラグ | ||||||
| 値 | publisher | |||||
